Key Record Dates
| ClinicalTrials.gov Identifier: | NCT00855218 |
|---|---|
| Brief Title: | A Phase II Randomized, Double-blind, Placebo-controlled Study of Sorafenib or Placebo in Combination With Transarterial Chemoembolization (TACE) Performed With DC Bead and Doxorubicin for Intermediate Stage Hepatocellular Carcinoma (HCC). |
| First Submitted : | March 3, 2009 |
| First Submitted that Met QC Criteria : | March 3, 2009 |
| First Posted : | March 4, 2009 (Estimate) |
| Results First Submitted : | August 23, 2012 |
| Results First Submitted that Met QC Criteria : | August 23, 2012 |
| Results First Posted : | September 24, 2012 (Estimate) |
| Last Update Submitted that Met QC Criteria : | July 18, 2017 |
| Last Update Posted : | August 18, 2017 |